Anatomical Study of the Arteries of the Skin on Amputation Legs (APIA)

September 11, 2018 updated by: Central Hospital, Nancy, France

PRIMARY OBJECTIVE Qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease.

SECONDARY OBJECTIVE To compare the distribution of cutaneous arteries observed on the legs of arteritic patients with that observed on non-arteritic legs (from bodies given to science).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Arterial patient coming to CHRU Nancy, in the Vascular and Endoluminal Surgery Department, to undergo leg amputation.

Usually, after the amputation of the leg in the operating theatre, the surgical waste is destroyed.

Instead of being destroyed, the leg will be used for research.

Study Type

Observational

Enrollment (Anticipated)

100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 95 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

arteritic patient coming to CHRUN as part of the care

Description

Inclusion Criteria:

  • Major Patient
  • Patient with late stage occlusive arteriopathy with lower limb amputation
  • Patient who did not oppose the search
  • Patient affiliated to a social security scheme

Exclusion Criteria:

  • Patients with infectious diseases not accessible in the anatomy laboratory
  • Woman of childbearing age without effective contraception
  • Persons referred to in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code :
  • Pregnant woman, parturient or nursing mother
  • Person deprived of liberty by a judicial or administrative decision,
  • Person under psychiatric care pursuant to Articles L.3212-1 and L.3213-1 of the Public Health Code
  • Person admitted to a health or social institution for purposes other than research
  • Minor person (not emancipated)
  • Adult subject to a legal protection measure (guardianship, trusteeship, protection of justice)
  • Major person who is not in a position to express consent and who is not subject to a legal protection measure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative mapping of the skin's arteries.
Time Frame: 72 hours after the dissection of the leg.

The leg will be transported in a container to the Anatomy Laboratory (Faculty of Medicine - University of Lorraine).

Within 72 hours of its arrival, the operating room will be dissected to qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease.

72 hours after the dissection of the leg.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 30, 2018

Primary Completion (Anticipated)

September 30, 2021

Study Completion (Anticipated)

September 30, 2021

Study Registration Dates

First Submitted

August 1, 2018

First Submitted That Met QC Criteria

August 1, 2018

First Posted (Actual)

August 7, 2018

Study Record Updates

Last Update Posted (Actual)

September 12, 2018

Last Update Submitted That Met QC Criteria

September 11, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-A02936-47

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arteritic Leg Ulcer

Clinical Trials on artericitc surgery

3
Subscribe